PREGCERT AQ 25MG INJECTION is used for the maintenance of early pregnancy in patients who faced documented history of repeated miscarriages due to luteal phase defect (a problem in menstrual cycle caused due to deficiency of progesterone during the midway of the menstrual cycle). It can also be used as an adjuvant to infertility techniques (such as in vitro fertilization (IVF) or gamete intra-fallopian transfer (GIFT)) to facilitate successful implantation of the fertilized egg in the uterus. It is also used to manage threatened abortions and to manage abnormal uterine bleeding caused due to hormonal imbalance. It can be used as a diagnostic tool in progesterone withdrawal testing to diagnose the endocrinal causes of secondary amenorrhea (irregular or lack of menstrual periods) and to judge the chances of pregnancy among infertile women. It contains a medicine called progesterone which is a steroid hormone that functions similar to the endogenous female sex hormones. Before receiving PREGCERT AQ 25MG INJECTION inform your doctor if you have any liver, kidney, or heart problems. You must also inform your doctor if you have diabetes, high blood pressure, asthma, epilepsy, or migraine headaches before receiving PREGCERT AQ 25MG INJECTION as a precaution. PREGCERT AQ 25MG INJECTION is not recommended for use in patients with breast cancer, ovarian cancer, uterine cancer, blood clot problems or any vaginal infections. PREGCERT AQ 25MG INJECTION is not recommended for use in breast-feeding women and in children and adolescents (below 18 years of age). PREGCERT AQ 25MG INJECTION can be used during the first three months of pregnancy. However, it should not be used in women who have ectopic pregnancy (pregnancy outside the womb) and in women who had a history of idiopathic jaundice (severe itching of the skin) or other skin problems during their earlier pregnancies. The most common side effects of receiving PREGCERT AQ 25MG INJECTION are pain, redness, itching,...
No content available
